FDA Advisers Back Novavax COVID Shots
ATLANTA, Ga. (AP) – A more traditional kind of COVID-19 vaccine is a step closer to becoming the fourth option for U.S. adults.
Advisers to the Food and Drug Administration voted Tuesday to recommend authorization of shots made by Novavax.
It’s a protein vaccine, a more conventional technology than the dominant Pfizer and Moderna shots, and the lesser-used Johnson & Johnson option.
It the FDA ultimately agrees, the Novavax shots could be an option for adults who haven’t yet gotten vaccinated.
The company eventually hopes to offer its shots as a booster, like they’re used in some other countries.